649 related articles for article (PubMed ID: 33679322)
21. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
Alrafiah AR
In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420
[TBL] [Abstract][Full Text] [Related]
22. The Unfolded Protein Response and the Role of Protein Disulfide Isomerase in Neurodegeneration.
Perri ER; Thomas CJ; Parakh S; Spencer DM; Atkin JD
Front Cell Dev Biol; 2015; 3():80. PubMed ID: 26779479
[TBL] [Abstract][Full Text] [Related]
23. γ-Oryzanol mitigates oxidative stress and prevents mutant SOD1-Related neurotoxicity in Drosophila and cell models of amyotrophic lateral sclerosis.
Zhang C; Liang W; Wang H; Yang Y; Wang T; Wang S; Wang X; Wang Y; Feng H
Neuropharmacology; 2019 Dec; 160():107777. PubMed ID: 31521619
[TBL] [Abstract][Full Text] [Related]
24. Role of autophagy in the pathogenesis of amyotrophic lateral sclerosis.
Lee JK; Shin JH; Lee JE; Choi EJ
Biochim Biophys Acta; 2015 Nov; 1852(11):2517-24. PubMed ID: 26264610
[TBL] [Abstract][Full Text] [Related]
25. 2-DE and MALDI-TOF-MS for a comparative analysis of proteins expressed in different cellular models of amyotrophic lateral sclerosis.
Di Poto C; Iadarola P; Bardoni AM; Passadore I; Giorgetti S; Cereda C; Carrì MT; Ceroni M; Salvini R
Electrophoresis; 2007 Dec; 28(23):4320-9. PubMed ID: 17979159
[TBL] [Abstract][Full Text] [Related]
26. Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD.
Chen H; Kankel MW; Su SC; Han SWS; Ofengeim D
Cell Death Differ; 2018 Mar; 25(4):648-662. PubMed ID: 29459769
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis.
Shi P; Wei Y; Zhang J; Gal J; Zhu H
J Alzheimers Dis; 2010; 20 Suppl 2():S311-24. PubMed ID: 20463400
[TBL] [Abstract][Full Text] [Related]
28. The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis.
Pollari E; Goldsteins G; Bart G; Koistinaho J; Giniatullin R
Front Cell Neurosci; 2014; 8():131. PubMed ID: 24860432
[TBL] [Abstract][Full Text] [Related]
29. Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals.
Carrí MT; Ferri A; Cozzolino M; Calabrese L; Rotilio G
Brain Res Bull; 2003 Aug; 61(4):365-74. PubMed ID: 12909279
[TBL] [Abstract][Full Text] [Related]
30. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
Singh A; Kukreti R; Saso L; Kukreti S
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
[TBL] [Abstract][Full Text] [Related]
31. A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy.
Bond L; Bernhardt K; Madria P; Sorrentino K; Scelsi H; Mitchell CS
Front Neurosci; 2018; 12():10. PubMed ID: 29416499
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotection by urate on the mutant hSOD1-related cellular and Drosophila models of amyotrophic lateral sclerosis: Implication for GSH synthesis via activating Akt/GSK3β/Nrf2/GCLC pathways.
Zhang C; Yang Y; Liang W; Wang T; Wang S; Wang X; Wang Y; Jiang H; Feng H
Brain Res Bull; 2019 Mar; 146():287-301. PubMed ID: 30690059
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.
Rinchetti P; Rizzuti M; Faravelli I; Corti S
Mol Neurobiol; 2018 Mar; 55(3):2617-2630. PubMed ID: 28421535
[TBL] [Abstract][Full Text] [Related]
34. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis.
Allen SP; Rajan S; Duffy L; Mortiboys H; Higginbottom A; Grierson AJ; Shaw PJ
Neurobiol Aging; 2014 Jun; 35(6):1499-509. PubMed ID: 24439480
[TBL] [Abstract][Full Text] [Related]
35. Glutathione in the Nervous System as a Potential Therapeutic Target to Control the Development and Progression of Amyotrophic Lateral Sclerosis.
Kim K
Antioxidants (Basel); 2021 Jun; 10(7):. PubMed ID: 34201812
[TBL] [Abstract][Full Text] [Related]
36. Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand.
Ramesh N; Pandey UB
Front Mol Neurosci; 2017; 10():263. PubMed ID: 28878620
[TBL] [Abstract][Full Text] [Related]
37. Understanding ALS: new therapeutic approaches.
Musarò A
FEBS J; 2013 Sep; 280(17):4315-22. PubMed ID: 23217177
[TBL] [Abstract][Full Text] [Related]
38. New links between SOD1 and metabolic dysfunction from a yeast model of amyotrophic lateral sclerosis.
Bastow EL; Peswani AR; Tarrant DS; Pentland DR; Chen X; Morgan A; Staniforth GL; Tullet JM; Rowe ML; Howard MJ; Tuite MF; Gourlay CW
J Cell Sci; 2016 Nov; 129(21):4118-4129. PubMed ID: 27656112
[TBL] [Abstract][Full Text] [Related]
39. Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis.
Goutman SA; Chen KS; Paez-Colasante X; Feldman EL
Handb Clin Neurol; 2018; 148():603-623. PubMed ID: 29478603
[TBL] [Abstract][Full Text] [Related]
40. Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Tokuda E; Furukawa Y
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27136532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
